


Healthcare News Roundup: Regulatory
HSMN NewsFeed - 12 Dec 2017
CompactCath Receives CE Mark For Its Flagship Discreet Intermittent Urinary Catheter
CompactCath Receives CE Mark For Its Flagship Discreet Intermittent Urinary Catheter
HSMN NewsFeed - 4 Dec 2017
Merck's Mavenclad (Cladribine Tablets) Approved for Relapsing-Remitting Multiple Sclerosis in Canada
Merck's Mavenclad (Cladribine Tablets) Approved for Relapsing-Remitting Multiple Sclerosis in Canada
HSMN NewsFeed - 20 Nov 2017
United Therapeutics Announces Additional Six Months Of Regulatory Exclusivity For Adcirca(R)
United Therapeutics Announces Additional Six Months Of Regulatory Exclusivity For Adcirca(R)
HSMN NewsFeed - 10 Nov 2017
Elanco, Aratana Announce Positive Opinion on GALLIPRANT(R) (grapiprant tablets) in Europe
Elanco, Aratana Announce Positive Opinion on GALLIPRANT(R) (grapiprant tablets) in Europe
HSMN NewsFeed - 9 Nov 2017
NICE Recommends Mavenclad (Cladribine Tablets) for Highly Active Multiple Sclerosis
NICE Recommends Mavenclad (Cladribine Tablets) for Highly Active Multiple Sclerosis
HSMN NewsFeed - 6 Nov 2017
Abbott's MitraClip Approved as First Transcatheter Mitral Valve Repair Device in Japan
Abbott's MitraClip Approved as First Transcatheter Mitral Valve Repair Device in Japan
